HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plasma concentrations of diazepam and N-desmethyldiazepam in newborn infants after intravenous, intramuscular, rectal and oral administration.

Abstract
Five newborn infants (birth weight 2900--3600 g) were given diazepam (Valium, LaRoche) for convulsive disorders in 4 equal doses intravenously, intramuscularly, rectally and orally with at least 24 hours intervals. Three infants were given doses of 1 mg diazepam/kg body weight, and 2 0.5 mg/kg. The parenteral solution of the drug was given intravenously, intramuscularly and rectally. Powder of tablets was given orally. After intravenous administration very high peak values of plasma-diazepam concentration were obtained (5775--10800 ng/ml after 1 mg/kg, 2750 and 6450 ng/ml after 0.5 mg/kg). Next to intravenous administration rectal administration caused the most rapid increase in plasma-diazepam concentration. Presumed anticonsulsive concentrations (150--300 ng/ml) were obtained within 5 min with 1 mg/kg as well as 0.5 mg/kg rectally. Rectal administration therefore could be a suitable treatment for seizures in the newborn infant. Accumulation of the main depressive metabolite N-desmethyldiazepam occurred in all infants. This phenomenon must be taken into account when repeated doses of diazepam are administered.
AuthorsA Langslet, A Meberg, J E Bredesen, P K Lunde
JournalActa paediatrica Scandinavica (Acta Paediatr Scand) Vol. 67 Issue 6 Pg. 699-704 (Nov 1978) ISSN: 0001-656X [Print] Sweden
PMID362801 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Nordazepam
  • Diazepam
Topics
  • Administration, Oral
  • Diazepam (administration & dosage, analogs & derivatives, blood, therapeutic use)
  • Female
  • Humans
  • Infant, Newborn
  • Infant, Newborn, Diseases (drug therapy)
  • Injections, Intramuscular
  • Injections, Intravenous
  • Nordazepam (blood)
  • Pregnancy
  • Rectum
  • Seizures (blood, drug therapy)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: